Astera Labs (ALAB) presented its growth trajectory at Citi's 2026 Global TMT Conference, highlighting a 98% revenue surge to $1.2 billion in Q2 2026. The company's revenue grew from $60 million at IPO to $392 million in the latest quarter, with EPS rising eightfold to $0.80. Gross margins remained strong at 75.13%, with a long-term target of 70%.
The company's stock price reached $304.67, up 5.48% from the previous close, reflecting a 136% return over the past six months. Market capitalization stands at $52.8 billion, with a high beta of 3.78.
Astera Labs' growth is fueled by its AI build-out, with CEO Jitendra Mohan noting that hyperscaler CapEx is expected to exceed $1 trillion next year. The company's product line, including Aries, Taurus, Leo CXL, Scorpio P, and Scorpio X, is designed to support the increasing demand for AI infrastructure.
Scorpio X, introduced in May 2024, is expected to become the largest product family by revenue in Q3 2026, overtaking Scorpio P. The company's content per accelerator/XPU has increased from sub-$100 at IPO to close to $1,000, with Scorpio X family expected to exceed $1,000 per XPU.
Astera Labs ships to all U.S.-based hyperscalers across its portfolio, with customer engagements growing from 10 to the high teens. The company's products compete with those from Broadcom, Marvell, NVIDIA, and AMD.
The company's long-term milestones include component-level optical sales and Leo CXL KV cache offload ramping in 2027, with narrow pluggable optics (NPO) initial revenue expected in the second half of 2027 and full-year NPO revenue in 2028.
